Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor?
Quyyumi
Arshed A
AA
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D015415:Biomarkers / Q000032:analysis; D001799:Blood Sedimentation; D003324:Coronary Artery Disease / Q000209:etiology* / Q000503:physiopathology*; D016207:Cytokines / Q000502:physiology; D004198:Disease Susceptibility / Q000503:physiopathology; D050171:Dyslipidemias / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007249:Inflammation / Q000503:physiopathology; D018384:Oxidative Stress / Q000502:physiology; D012307:Risk Factors; D012720:Severity of Illness Index
D018501:Antirheumatic Agents; D015415:Biomarkers; D016207:Cytokines; D005938:Glucocorticoids; D007166:Immunosuppressive Agents